TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

AMNEAL PHARMS

CardiovascularInfectious DiseaseOncology
Generics

AMNEAL PHARMS is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Oncology. Key products include VORICONAZOLE.

2002
Since
150
Drugs
-
Trials
2379
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 26%
9 drugs
Infectious Disease 21%
7 drugs
Oncology 21%
7 drugs
Neurology 18%
6 drugs
Immunology 15%
5 drugs

Pipeline Strength Pro

Loading...